Novartis Ag (NVS)

Trade NVS now with
12/15/2017 1:04:53 AM Bruno Strigini, CEO Novartis Oncology, To Retire For Personal Reasons
12/8/2017 1:22:40 AM Sandoz Announces New Phase I Data Showing Proposed Biosimilar Pegfilgrastim Matches Reference Medicine
12/7/2017 7:01:00 AM Advanced Accelerator Applications Announces Commencement Of Novartis Tender Offer
12/7/2017 1:05:20 AM Novartis Begins Tender Offer For Advanced Accelerator Applications
12/5/2017 4:04:20 PM Advanced Accelerator Applications Board Recommends $3.9 Bln All Cash Tender Offer By Novartis
11/30/2017 1:17:36 AM Novartis: Cosentyx Provided Sustained Improvements In Nail And Palmoplantar Psoriasis Out To 2.5 Years
11/27/2017 1:17:26 AM Novartis Reports Positive Results From FLASH Study; Study Met Primary Endpoint
11/20/2017 1:22:37 AM Novartis: Tasigna (nilotinib) Secures EU Approval For First And Second-line Treatment Of Ph+ CML-CP In Children
11/15/2017 9:34:14 AM Novartis, ASCP And ACS Join Forces To Fight Cancer In Ethiopia, Uganda And Tanzania